Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Clinical trial NCT05410821 · COMPLETED

Trial details

NCT number: NCT05410821
Sponsor: The First Affiliated Hospital of Xiamen University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Thyroid Gland Carcinoma Refractory Thyroid Gland Papillary Carcinoma Refractory Thyroid Gland Follicular Carcinoma Refractory Thyroid Gland Hurthle Cell Carcinoma

Start date: 2022-06-15
Primary completion: 2024-06-15
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.